CCAGW Joins Coalition Opposing Medicare Drug Price Negotiation Program
Letters to Officials
January 29, 2025
The Honorable Donald J. Trump
The White House
1600 Pennsylvania Avenue NW
Washington, DC 20500
Dear President Trump,
In a last-ditch effort to impose its failed healthcare policy on your Administration, the Biden Administration unveiled the next round of drugs selected for the so-called Medicare Drug Price Negotiation Program in the final days before leaving office. These so-called “negotiations,” authorized by the 2022 Inflation Reduction Act (IRA) and which are not negotiations at all, are nothing more than bureaucracy-imposed price controls on critical medications. As the Coalition Against Socialized Medicine (CASM), we strongly urge you to immediately delay the implementation of this Biden-era program — before February 1, when harmful IRA triggers kick in — that will lead to continuous barriers to healthcare access in the short-term and, in the long-term, the dissolution of our free-market healthcare system. We urge you to freeze the Biden prescription drug price controls and chart a new path that diverges from our nation's current march toward socialized medicine.
Anyone who has taken an introductory economics class or studied history knows that price controls never work. They disincentivize development, lead to scarcity, and create overall losses for society. In the case of lifesaving medication, America’s patents cannot afford the reduction in the development of new medical advancements we are already beginning to see thanks to the IRA.
The tangible negative impacts of the IRA extend beyond decreases in medical innovation. Biden’s prescription drug price controls have caused premiums to increase and options to decrease for seniors in Medicare Part D. In 2024, average premiums for Part D plans increased by 21 percent, while the number of plans available has reached an all-time low since the program’s inception. Put plainly, this disastrous government overreach is chipping away at the positive aspects of America’s healthcare system while ushering in a time-tested failure of a policy that goes against everything our nation stands for. Biden’s imposition of the second phase of the Medicare Drug Price Negotiation program was nothing more than a last-minute move to try and block your efforts to implement sound healthcare policy. CASM urges you to closely examine the negative aspects of this program on American taxpayers, patents and the economy and announce an official delay of IRA implementation by February 1, before the next phase of the program begins. The future of America’s free healthcare market depends on it.
Thank you for your attention to this urgent mater.
Sincerely,
Andrew Langer
Executive Director, Coalition Against Socialized Medicine
Tom Schatz
President, Council for Citizens Against Government Waste
Matt Schlapp
Chairman, Conservative Political Action Coalition
George Landrith
President, Frontiers of Freedom
Phil Kerpen
President, American Commitment
Mario Lopez
President, Hispanic Leadership Fund
Dee Stewart
President, Americans for a Balanced Budget
Carrie Lukas
President, Independent Women's Forum
Ryan Ellis
President, Center for a Free Economy
Jerry Rogers
Vice President, Institute for Liberty
Anthony J. Zagotta
President, Center for American Principles
Seton Motley
President, Less Government
Dan Mitchell
President, Center for Freedom and Prosperity
Pete Sepp
President, National Taxpayers Union
Jeffrey Mazzella
President, Center for Individual Freedom
John Tamny
President, Parkview Institute
Ginerva Joyce-Myers
Executive Director, Center for Innovation and Free Enterprise
Karen Kerrigan
President and CEO, Small Business and Entrepreneurship Council
David McIntosh
President, Club for Growth
David Williams
President, Taxpayers Protection Alliance
James Edwards
President, Conservatives for Property Rights
Kent Kaiser
Executive Director, Trade Alliance to Promote Prosperity
Matthew Kandrach
President, Consumer Action for a Strong Economy